Benign biliary stricture is a focal or segmental narrowing of bile ducts due to non-malignant causes, most commonly postoperative (cholecystectomy, liver transplantation), chronic pancreatitis, and inflammatory causes (PSC, IgG4-related cholangitis, radiation). Iatrogenic strictures most commonly develop after cholecystectomy (0.2-0.7%) and are related to bile duct clip, thermal damage, or transection. Benign strictures typically show short segment (<2 cm), smooth concentric narrowing with smooth wall contour — lacking the irregular wall thickening and mass component of malignant strictures.
Age Range
30-75
Peak Age
55
Gender
Equal
Prevalence
Uncommon
Benign biliary strictures develop through multiple mechanisms: (1) Iatrogenic — clipping, transection, or thermal damage to bile duct during surgery leads to ischemia and fibrosis. Thermal energy (electrocautery, laser) creates delayed necrosis in the duct wall and fibrous stricture develops during healing. (2) Inflammatory — in chronic pancreatitis, periductal fibrosis compresses intrapancreatic CBD. In IgG4-related cholangitis, lymphoplasmacytic infiltration and storiform fibrosis thickens the duct wall. (3) Ischemic — hepatic artery stenosis/thrombosis after liver transplantation impairs bile duct perfusion (bile ducts are exclusively supplied by arterial blood). On imaging, benign strictures show smooth concentric narrowing, proximal dilatation, and smooth wall contour. Fibrous tissue being collagen-dominant may show delayed phase enhancement. Bile stasis and secondary stone formation may be seen proximal to the stricture.
Short segment (<2 cm), smooth concentric narrowing of bile duct on MRCP — symmetric, smooth wall contour, 'waist-like' focal luminal narrowing without mass or nodular component. Together with proximal dilatation and distal normal caliber, this is the characteristic appearance of benign biliary stricture.
Smooth concentric focal narrowing of bile duct on MRCP — 'waist-like' short segment stricture. Dilatation proximally, normal-caliber duct distally. In benign strictures, narrowing is symmetric with smooth contour, no wall irregularity or mass. Stricture transition may be gradual ('pencil-tip' pattern) or abrupt. If multiple strictures are present, PSC or anastomotic stricture should be considered.
Report Sentence
Smooth concentric short-segment focal narrowing of the bile duct is seen on MRCP with proximal biliary dilatation; consistent with benign biliary stricture.
Focal narrowing of bile duct with proximal dilatation on portal venous phase. Wall at stricture site is smooth and thin, enhancement is symmetric. No peristructural mass or lymphadenopathy. Presence of surgical clips suggests iatrogenic etiology. In intrapancreatic CBD stricture, chronic pancreatitis findings (calcification, atrophy) in pancreatic head accompany.
Report Sentence
Focal smooth narrowing of the bile duct with proximal dilatation is noted without peristructural mass; consistent with benign biliary stricture.
Delayed phase enhancement of duct wall at stricture site on contrast-enhanced T1 series — reflecting late contrast uptake of fibrous tissue. Minimal enhancement in early phase, progressive increase pattern in delayed phase (3-5 min). Smooth symmetric enhancement favors benign, irregular asymmetric enhancement favors malignancy.
Report Sentence
Progressive delayed phase enhancement of the duct wall at the stricture site is noted; a finding consistent with fibrous benign stricture.
Proximal bile duct dilatation on US (intrahepatic >2 mm or CHD/CBD >6 mm) — stricture site usually cannot be directly visualized by US but dilatation pattern suggests obstruction. Intrahepatic duct dilatation appears as 'shotgun sign' (double barrel — portal vein and bile duct parallel). MRCP is needed to determine stricture level.
Report Sentence
Intrahepatic bile duct dilatation is noted suggesting obstructive etiology; MRCP is recommended for stricture level determination.
Delayed phase (3-5 min) periductal fibrous tissue enhancement at stricture site — smooth concentric hyperdense ring. Delayed enhancement reflects late contrast uptake of fibrous tissue. In IgG4-related cholangitis, prominent periductal enhancement and duct wall thickening are typical. In post-radiation strictures, periductal changes matching the radiation field are seen.
Report Sentence
Periductal enhancement at the stricture site is noted on delayed phase; consistent with fibrotic process.
No significant diffusion restriction at stricture site on DWI — ADC values are normal or mildly reduced. This is a distinguishing feature from marked diffusion restriction (low ADC) seen in malignant strictures. In malignant strictures, tumor cellularity causes diffusion restriction, while in benign fibrous strictures, cellularity is low.
Report Sentence
No significant diffusion restriction at the stricture site on DWI; no findings favoring malignancy.
Criteria
Stricture developing after surgery — most commonly cholecystectomy (0.2-0.7%), liver transplantation (5-30%), after hepatic resection. Surgical clip or anastomosis line at stricture site. Jaundice within weeks-months after surgery.
Distinct Features
Surgical clip at stricture level on CT, single focal stricture, surgical history, anastomotic line stricture typical after transplant.
Criteria
Periductal fibrosis of chronic pancreatitis compresses intrapancreatic CBD. Long segment stricture (>2 cm), gradual narrowing. Pancreatic parenchymal calcification, atrophy, and duct dilatation accompany.
Distinct Features
Calcification and atrophy in pancreatic head, intrapancreatic location, gradual 'pencil-tip' pattern, pancreatic duct dilatation.
Criteria
Biliary involvement of IgG4-related disease. Multifocal or long segment strictures, prominent smooth wall thickening (>3 mm), marked delayed phase enhancement. Autoimmune pancreatitis frequently accompanies. Elevated serum IgG4, dramatic response to steroid therapy.
Distinct Features
Prominent smooth concentric wall thickening, diffuse or multifocal strictures, autoimmune pancreatitis association, steroid response.
Distinguishing Feature
Cholangiocarcinoma shows irregular wall thickening, mass, DWI restriction, and irregular asymmetric enhancement. Benign stricture shows smooth concentric narrowing, no mass, no significant DWI restriction.
Distinguishing Feature
PSC has multifocal intra+extrahepatic strictures with intervening dilatation ('beaded appearance'). Benign stricture is usually at a single focal location with identifiable specific etiology (surgical, pancreatitis).
Distinguishing Feature
In Mirizzi syndrome, impacted stone at cystic duct level extrinsically compresses CHD — stone is visualized. In benign stricture, there is no stone, narrowing arises from intramural fibrous process.
Distinguishing Feature
Distal cholangiocarcinoma may show mass/wall thickening, DWI restriction, and vascular invasion. Benign stricture has smooth wall, no diffusion restriction, no vascular invasion.
Urgency
routineManagement
interventionalBiopsy
NeededFollow-up
6-monthEndoscopic approach (ERCP with balloon dilatation + stent) is first-line treatment for benign biliary strictures. Percutaneous transhepatic approach or surgical revision (Roux-en-Y hepaticojejunostomy) may be needed for refractory strictures. Steroid therapy gives dramatic response in IgG4-related cholangitis. Benign-malignant differentiation is critical — brush cytology or biopsy should be performed in suspicious cases. Follow-up is with US/MRCP and liver function tests. Long-term stent placement carries occlusion and cholangitis risk.
Benign biliary stricture is treated endoscopically (ERCP + balloon dilatation/stent) or surgically (hepaticojejunostomy). Malignancy should be excluded (brush cytology, biopsy). Recurrent strictures may require surgical reconstruction.